Trial intelligence / Profile preview

Phase 1 Multiple Oral Dose Study of DS-8500a in Healthy Japanese Males

jRCT2080223495Phase 1

Sponsor
Daiichi Sankyo Co., Ltd.
Start
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing DS-8500a arm with Placebo arm (2 arms).

02

Drugs

firuglipel
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on jRCT2080223495.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080223495.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call